Clinical Trials Insight: 700012586
Latest Information Update: 18 Jan 2010
Price :
$35 *
At a glance
- Drugs NGX 267 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors TorreyPines Therapeutics
- 01 Aug 2006 Status change
- 01 Mar 2006 New trial record.